Reata Pharmaceuticals Inc... (RETA)
NASDAQ: RETA
· Real-Time Price · USD
172.36
0.04 (0.02%)
At close: Sep 25, 2023, 10:00 PM
Reata Pharmaceuticals Revenue
Reata Pharmaceuticals reported an annual revenue of $2.22M, reflecting a -80.71% growth. For the quarter ending June 30, 2023, Reata Pharmaceuticals generated $22.75M in revenue.
Revenue (ttm)
2.22M
Revenue Growth
-80.71%
Price / Sales Ratio
622.68
Revenue / Employee
6.9K
Employees
321
Market Cap
6.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2022 | 2.22M | -80.71% |
| Dec 31, 2021 | 11.49M | +27.40% |
| Dec 31, 2020 | 9.02M | -65.99% |
| Dec 31, 2019 | 26.52M | -50.52% |
| Dec 31, 2018 | 53.59M | +11.51% |
| Dec 31, 2017 | 48.06M | -3.61% |
| Dec 31, 2016 | 49.86M | -0.92% |
| Dec 31, 2015 | 50.32M | -3.15% |
| Dec 31, 2014 | 51.95M | +1.47% |
| Dec 31, 2013 | 51.2M | n/a |